Big Capital Avoids IPL, and No Small Brand Can Monopolize It Either

There’s a Strange Pattern in This Market

Ask any VC whether they’d invest in an IPL hair removal brand, and you’ll get a polite but firm no. Ask the owner of a small or mid-sized beauty brand whether they can make this category theirs, and they’ll tell you about a free-for-all with no winner.

Big capital really hasn’t entered. There are no SoftBank-scale checks being thrown at IPL startups. At the same time, no company has managed to monopolize the market.

Put those two facts together and you get a fascinating contradiction. Behind it lie both the general rules of how consumer categories mature and the structural predicament specific to IPL.

I’ve worked in this industry for many years, dealing with molds, certification, and supply chains every day, and I’ve read plenty of industry reports and white papers — the numbers below all have sources. Let me explain why IPL turned out this way, based on what I’ve seen.

Why Big Capital Won’t Invest

Repeat Purchase Rates Are Too Low

An IPL hair removal device is a durable good. A customer buys one, uses it for 8 to 12 weeks, sees less hair, and may never buy a second one. Replacement lamp cartridges do exist, but not many people actually buy them.

The contrast makes it clear. SaaS brings in recurring revenue every month; consumables like shampoo, razors, and skincare serums have stable repeat purchases. That’s the revenue structure VCs love. IPL offers none of it.

According to industry analysis, the global hair removal device market was worth about $858 million in 2025, projected to reach $1.73 billion by 2032, a CAGR of 10.7%. Those numbers aren’t ugly, but they’re far from explosive. The whole category is smaller than many single-brand skincare lines.

A category that tops out at around $1.7 billion globally is not something people managing multi-billion-dollar funds get excited about. That’s perfectly normal.

Capital-Intensive, But No Scale Moat

Making an IPL hair removal device costs money in these places. Injection molding tooling, $50,000 to $150,000 per set. A PCB assembly line to build. Optical components to source — reflectors, filters, lenses. And certification: in the US, FDA 510(k) alone runs $5,000 to $22,000 depending on small business status.

These are all sunk costs. The tricky part: once a mold is cut, after finishing the first brand’s order, producing for a second brand adds marginal cost so low it’s negligible. The result is a supplier-driven market — the value gets captured by the contract manufacturers, not the brands.

This is exactly the kind of category big capital avoids: pricing power sits with the supplier, not the brand.

Regulation Raises the Bar Without Granting Exclusivity

In the US, IPL hair removal devices are regulated as Class II medical devices, FDA product code OHT. Getting clearance takes time and money — but once you have it, it doesn’t keep latecomers out.

Pharmaceuticals use patents to keep competitors away for years. IPL technology is mostly past its patent period. Any manufacturer can take an existing predicate device on the market, build a substantially equivalent device, and go get clearance. The FDA’s official definition of 510(k) is one sentence: prove your device is substantially equivalent to a legally marketed device, and if equivalence holds, it’s cleared. That’s what the FDA’s official explanation says — the predicate can be any legally marketed device.

Regulation puts a gate at the entrance, but it grants no exclusivity. Once your device is cleared, you compete for the same market against dozens of brands that cleared via the same predicate device.

A Three-Tier Market Structure, Fragmented by Design

Industry reports largely agree on how the competitive landscape is layered, in three tiers. Let me make clear who sits where.

Tier One: Consumer Electronics Giants

Brand	Parent Company	Market Role
Philips	Philips	Global leader, broad distribution
Braun	Procter & Gamble	Premium positioning, strong retail presence
Panasonic	Panasonic	Strong in Asian markets

Together the three hold a significant global share. But that share counts both laser and IPL technologies, and it includes professional devices too.

None of the giants has pursued aggressive consolidation in IPL. For Philips, Braun, and Panasonic, IPL is just one product line among hundreds. They don’t need to win this category — joining in and making money is enough.

Tier Two: D2C Specialist Brands

Brand	HQ	Notes
RoseSkinCo	USA	D2C, driven by Meta ad spend
SmoothSkin	Cyden, UK	Holds the original IPL patents
Kenzzi	USA	Influencer-heavy model

These brands reached meaningful scale without big funding rounds, and their playbooks share common threads.

• Digital marketing is their home turf — they’re good at Meta, Instagram, and YouTube advertising.
• They position into niches, from affordable premium to clinical efficacy, each claiming a corner.
• They iterate fast, releasing a new model generation every 12 to 24 months.

But their global shares are all low single digits. In competitive analysis reports, the gap between tier one and tier two is still obvious.

Tier Three: Legacy Innovators

Brand	HQ	Significance
Silk’n	Israel	Pioneer of HPL (home pulsed light)
CosBeauty	China	Presence in Asian markets
Ya-Man	Japan	Premium positioning in Japan

Silk’n deserves a closer look. Founder Shimon Eckhouse drove the early commercialization of IPL in Israel in the 1990s — he’s one of the founding figures of this technology. With that kind of first-mover advantage, Silk’n still never reached the global scale of Philips or Braun.

Tier three proves one thing: being ahead technologically doesn’t mean the market will reward you.

The China Market: Big Players Keep Falling

If you want to see how hard it is to monopolize IPL, just look at China.

Ulike Leads, But Is Far From a Monopoly

Per the 2025 home IPL industry white paper, Ulike holds about 47% of the Tmall IPL market. JOVS is second at 11.25%. Together the top two are just past 58% — and that’s within a single sales channel. The remaining 42% is scattered across dozens of brands.

That’s a fragmented market with a temporary leader, nowhere near a monopoly.

The Big Players Who Fell

Xiaomi

Xiaomi tried IPL through its ecosystem approach; several affiliated brands released hair removal devices. Combined, their market share never exceeded 1%.

Xiaomi’s strength is smart connected devices, hooking users through software. An IPL device has neither a software ecosystem nor a subscription service. None of Xiaomi’s advantages apply.

Haier

Haier did worse than Xiaomi. A home appliance giant showing up to sell beauty devices — the positioning was off, and consumers were naturally suspicious. Haier’s share never reached a measurable level.

Cyden Never Made It in China

Cyden, SmoothSkin’s parent company, tried entering the Chinese market directly. It held the foundational IPL patents and made premium products — and still didn’t take off. According to the verifiable market data, Cyden’s share in China is negligible; you won’t find it in the top ten of any mainstream report.

Where did it lose? Look at three things. Brand awareness: Chinese consumers recognize Philips, Braun, Ulike, and JOVS; the name SmoothSkin means nothing to them. Distribution: no flagship stores on Tmall or JD.com, so visibility was minimal. And pricing: Western premium pricing with no corresponding brand equity to back it up.

Why Nobody Can Monopolize It

Four structural barriers stand in the way.

Barrier One: Low Manufacturing Barriers

The IPL component supply chain is mature and concentrated in Guangdong. Hire an industrial designer, $10,000 to $30,000. Find a contract manufacturer — orders start at 500 units. Then use a predicate device to go through 510(k) for FDA clearance.

The total investment to launch a minimum viable IPL brand is often just $50,000 to $100,000. Tens of thousands of founders can reach that number.

Barrier Two: D2C Levels the Channel

IPL devices sell mainly online, and home use is the biggest segment. Online channels favor flexible brands that know marketing; asset-heavy incumbents get no advantage.

A small brand putting $100,000 into Meta ads can compete for the same customers as Philips. The field is flatter than you’d think.

Barrier Three: Technology Has Become a Commodity

The core components — flash lamp, reflector, filter, capacitor bank — haven’t fundamentally changed in decades. There are incremental improvements, like sapphire cooling and faster repetition rates, but no manufacturer can own them exclusively.

Consumers have learned to compare fluence (J/cm²), cooling technology, and skin sensors. These are now just tickets to entry — anyone can pull them out.

Barrier Four: The Pearl River Delta Supply Chain Effect

IPL manufacturing is concentrated in the Pearl River Delta, and the same factory is often running orders for several brands at once, with heavily overlapping component suppliers.

Any brand trying to be exclusive will find its “exclusive feature” in a competitor’s product within months. After long enough in this business, you stop taking the word “exclusive” seriously.

What Conditions Would Take to Create a Monopoly

Clearing these barriers would require three things to change at once.

Condition One: Truly Differentiated Technology

No home device has achieved permanent hair removal so far — only reduction. If a brand could deliver permanence in 3 to 4 sessions at home, both the premium and the customer loyalty would follow.

Today’s technology delivers semi-permanent reduction, still short of “permanent.” Consumers want “permanent” but get “long-lasting reduction” — that gap keeps generating dissatisfaction and has kept anyone from becoming a dominant brand.

Condition Two: A Consumables Business Model

The most successful consumer categories all have high repeat purchases. If an IPL brand could convert customers into ongoing consumable buyers — specialized gel refills, replacement heads, skincare serums — it would have the recurring revenue that attracts capital.

Condition Three: Tighter Regulation

Suppose the FDA sharply raised the 510(k) bar and made every IPL device go through a de novo application. The cost of entry would jump from $50,000 to over $1 million, and most small players would be cleared out of the game.

There is currently no sign the FDA plans to do anything like that.

This Contradiction Will Keep Existing

Back to the contradiction at the start.

Big capital doesn’t invest in IPL because repeat purchase rates are too low, the total market is too small, and the value in manufacturing gets taken by suppliers. Small brands can’t build a monopoly because entry barriers are low, D2C levels the competition, the technology is commoditized, and the supply chain feeds similar components to every competitor.

This contradiction is built into the category’s structure, and it will keep existing. IPL will likely stay fragmented for a long time — hundreds of small and mid-sized brands each making money, with no single buyer willing to pay for dominance.

For entrepreneurs, this is good news. Low barriers, a level field, and no sign of the giants expanding aggressively.

For VCs, it’s a hard pass. And that’s exactly why this category stays open for people willing to build slowly, profitably, and without outside capital.